WebOverview. Tradjenta (Linagliptin) is a prescription medicine that is used along with diet and exercise to treat type 2 diabetes. Likewise, it is an oral drug. Tradjenta moreover is the brand name under which the generic drug Linagliptin is sold. It is similarly also marketed internationally as Trajenta. WebTradjenta savings and support Help your eligible patients get the support they need by signing up for My TRADJENTA Support—which includes a savings card, helpful emails and online tools. TREATMENT TRACKER A diet, medication, and exercise tracking tool that helps patients monitor their lifestyle and medication habits.
Tradjenta Savings Card Terms and Conditions
WebGLYXAMBI is a prescription medication containing two medicines, empagliflozin (JARDIANCE) and linagliptin (TRADJENTA). GLYXAMBI can be used along with diet and exercise to lower blood sugar in adults with type 2 diabetes, and can be used in adults with type 2 diabetes who have known cardiovascular disease when empagliflozin, one of the ... WebLinagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus. Brand Names Glyxambi, Jentadueto, Tradjenta, Trajenta, Trijardy Generic Name Linagliptin DrugBank … dept of human resources montgomery alabama
Tradjenta oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
WebLinagliptin is in a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the amounts of certain natural substances that lower blood sugar when it is high. Linagliptin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of ... WebLinagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. Web> Monitor patient for signs and symptoms of pancreatitis. If pancreatitis is suspected, promptly discontinue linagliptin and initiate appropriate management. After: > Inform patient of the potential risks and benefits of linagliptin and of alternative modes of therapy. > Instruct patient to take drug only as prescribed. dept of human resources huntsville al